Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C

By Yasuhito Tanaka, N. Nishida, M. Sugiyama, M. Kurosaki, K. Matsuura, N. Sakamoto, M. Nakagawa, M. Korenaga, K. Hino, S. Hige and 19 more. Nature Genetics, 2009

1,744 citations recorded by the source corpus.

Subfields: Epidemiology, Hepatology

View Paper: https://www.semanticscholar.org/paper/976015880963f4a7eb6fab1ccf036b85f07c5f2f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. O. Yoshie
2. A. Zlotnik

Citations in the corpus

• The Chemokine Superfamily Revisited (2012, positive): “Until recently the treatment for chronic carriers was a combination therapy of interferon alpha (IFN-a) and ribavirin, but 50% of the patients failed to clear the virus after this treatment (Tanaka et al., 2009).”